
Quarterly Result30 Oct 2026, 05:21 pm
Anuh Pharma Declares Unaudited Q2 FY27 Results
AI Summary
Anuh Pharma Ltd has announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The company reported its financial performance for the period, adhering to Ind AS 34 standards. The results were reviewed by the Audit Committee and approved by the Board of Directors on October 30, 2026, and have undergone a limited review by the statutory auditors. The company operates in the Bulk drug and Chemicals segment and has no subsidiaries or joint ventures.
Key Highlights
- Unaudited financial results for Q2 FY27 declared.
- Results approved by the Board on October 30, 2026.
- Limited review completed by statutory auditors.
- Company operates in Bulk drug and Chemicals segment.
- No subsidiaries or joint ventures reported.
Price Impact
More from ANUHPHR